2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1881925204 MD
Verify on CMS →

PADMA VENKATARAMAN, MD

Endocrinology, Diabetes & Metabolism Physician in MUSKOGEE, Oklahoma. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 295 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$13.23
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: PADMA VENKATARAMAN, MD is a Endocrinology, Diabetes & Metabolism Physician ([object Object]) practicing in MUSKOGEE, Oklahoma with a Medicare Part D prescribing footprint of 2K claims across 295 beneficiaries — 52% brand-name prescribing . Industry payments of $13.23 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: PADMA VENKATARAMAN, MD filed 1,886 Medicare Part D claims in 2023 across MUSKOGEE, Oklahoma. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

PADMA VENKATARAMAN, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

PADMA VENKATARAMAN, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 01/25/2010

NPI 1881925204

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

1,886 29% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Oklahoma

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Oklahoma providers

Oklahoma providers

Endocrinology, Diabetes & Metabolism Physician share within Oklahoma

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Oklahoma

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PADMA VENKATARAMAN, MD is a Endocrinology, Diabetes & Metabolism Physician provider practicing in MUSKOGEE, Oklahoma, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1881925204. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

PADMA VENKATARAMAN, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 350 S 40TH ST, MUSKOGEE, OK, 74401, with a listed phone of (918) 683-0753. NPI 1881925204 was issued on 01/25/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what VENKATARAMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,886 prescription claims written by this provider, covering 295 Medicare beneficiaries and totaling roughly $882K in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

350 S 40TH ST
MUSKOGEE, OK 74401

Provider Details

NPI 1881925204
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 01/25/2010

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PADMA VENKATARAMAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$13

Largest payer

Insulet Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

PADMA VENKATARAMAN, MD — brand share 52.0%
Specialty average (est.)

52% brand-name claims vs 48% generic, on 1,886 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,886
Total Claims
$882K
Total Drug Cost
295
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,261
Total Day Supply
125,812
Brand vs Generic
52% brand / 48% generic
Brand Drug Cost
$789K
Generic Drug Cost
$29K

Patient Demographics

Average Patient Age
72.1 years
Avg HCC Risk Score
1.85
Gender Split
65% female / 35% male
Age Distribution
<65: 34, 65-74: 148, 75-84: 95, 85+: 18

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
238
Tresiba Flextouch U-100
Insulin Degludec
114
Ozempic
Semaglutide
101
Synthroid
Levothyroxine Sodium
80
Trulicity
Dulaglutide
60
Glimepiride
58
Novolog Flexpen
Insulin Aspart
56
Metformin Hcl
48
Repaglinide
45
Jardiance
Empagliflozin
44

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How PADMA VENKATARAMAN, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

PADMA VENKATARAMAN, MD's 1,886 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Oklahoma

Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as VENKATARAMAN.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PADMA VENKATARAMAN, MD's specialty?
PADMA VENKATARAMAN, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in MUSKOGEE, Oklahoma. Credentials: MD.
How much does PADMA VENKATARAMAN, MD prescribe under Medicare Part D?
In 2023, PADMA VENKATARAMAN, MD wrote 1,886 Medicare Part D claims totaling $882K in drug costs for 295 beneficiaries.
Where is PADMA VENKATARAMAN, MD located?
PADMA VENKATARAMAN, MD is located at 350 S 40TH ST, MUSKOGEE, OK, 74401. Phone: (918) 683-0753.
What is PADMA VENKATARAMAN, MD's NPI number?
PADMA VENKATARAMAN, MD's National Provider Identifier (NPI) is 1881925204, issued on 01/25/2010.
Does PADMA VENKATARAMAN, MD prescribe more brand-name or generic drugs?
PADMA VENKATARAMAN, MD's prescribing is 52% brand-name and 48% generic drugs by claim count, with $789K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does PADMA VENKATARAMAN, MD prescribe most often?
Based on 2023 Medicare Part D data, PADMA VENKATARAMAN, MD's most frequently prescribed drugs include Levothyroxine Sodium, Tresiba Flextouch U-100, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PADMA VENKATARAMAN, MD accept Medicare?
PADMA VENKATARAMAN, MD appears in CMS Medicare data with 1,886 Part D claims and 295 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PADMA VENKATARAMAN, MD's credentials?
PADMA VENKATARAMAN, MD's NPI is 1881925204 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology